IDEXX Laboratories (NasdaqGS:IDXX) Conference February 26, 2026 09:50 AM ET Company ParticipantsAndrew Emerson - EVP and CFOMichael Ryskin - Managing DirectorMike Lane - EVP and GM of Global Reference Laboratories, Diagnostic Solutions, Information TechnologyModeratorLadies and gentlemen, the program is about to begin. At this time, it is my pleasure to turn the program over to your host, Michael Ryskin. You may begin.Michael RyskinGreat. Thanks, everyone. Thanks for joining us, and welcome to today's event ...

Core Insights - Procter & Gamble (P&G) exceeded expectations in organic sales and margins for Q1 of fiscal 2026, maintaining its full-year revenue and EPS guidance unchanged [1] - Bank of America analysts reaffirmed a Buy rating and increased the price target to $175, citing consistent execution and innovation-driven market share gains despite a slowdown in consumption [1][10] Consumption Trends - Consumption trends for P&G softened during the quarter, decreasing from approximately 2.4% to a range of 1.8-1.9%, with near-term growth projected between 1.5% and 2% [2] Competitive Response - In response to increased competitive promotions, P&G is focusing on innovation-led growth, launching new products such as Tide liquid and Tide EVO in laundry care, and Pampers and Luvs in baby care [3] Market Share Performance - Six out of P&G's seven regions either maintained or expanded market share, with a notable 7% gain in Latin America; Europe remained stable, while Asia Pacific and the Middle East experienced slight declines [4] Tariff and Cost Expectations - P&G's expected tariff-related costs have been revised to $500 million, down from $750 million previously, due to material exclusions and adjusted sourcing strategies [5] Growth Outlook - The second quarter of 2026 is anticipated to be the weakest growth period of the year, but management expects a rebound in the second half, driven by ongoing innovation and supply chain improvements [6] Financial Estimates - Bank of America has slightly increased its EPS estimates for 2026, 2027, and 2028 to $7.00, $7.35, and $7.75, respectively, reflecting the positive impact of the first-quarter performance [8] - The brokerage forecasts second-quarter organic sales growth of 0.5%, down from a previous estimate of 1.5%, and a 2026 organic growth of 1.6%, reduced from 2% [9] Valuation and Price Target - Bank of America maintains a Buy rating on P&G with a price target of $175, based on a 24.5x CY26E P/E multiple, reflecting a 20% valuation premium for household and personal care peers due to P&G's long-term growth potential [10]